Whalesbook
India's primary market is seeing significant activity, concentrated within the Small and Medium Enterprise (SME) segment. This week, eight SME companies are launching Initial Public Offerings (IPOs), aiming to collectively raise around ₹440 crore.
This strong pipeline of SME offerings contrasts with the continued silence from the mainboard segment, which has seen no new listings for two consecutive weeks.
SME IPOs Flood the Market
Q-Line Biotech is leading the pack, aiming to raise over ₹214 crore, making it the year's largest SME IPO. Other companies launching this week include NFP Sampoorna Foods (₹24.53 crore), Teamtech Formwork Solutions (₹50.2 crore), Vegorama Punjabi Angithi (₹38.38 crore), Harikanta Overseas (₹25.6 crore), Bio Medica Laboratories (₹45.5 crore), and Autofurnish (₹14.6 crore). M R Maniveni Foods will close the week's SME IPO activity, seeking over ₹27 crore.
Two SME firms, Goldline Pharmaceutical and RFBL Flexi Pack, are scheduled to list on May 19. Goldline Pharmaceutical's IPO achieved a subscription of 782 times, while RFBL Flexi Pack's issue was subscribed 20.4 times. These strong subscription numbers reflect heightened investor interest in SME offerings.
Mainboard Market Remains Stalled
The mainboard segment's inactivity is due to cautious investor sentiment, volatile market conditions, and a recalibration of valuations. Companies are delaying launches, waiting for more favorable market conditions and better listing gains, a trend seen where many mainboard IPOs struggled with discount listings.
Geopolitical tensions and inflation concerns have further dampened broader market sentiment, impacting foreign institutional investor (FII) flows and overall liquidity. This has led to a significant slowdown in mainboard IPOs, prompting companies to re-evaluate their listing strategies.
Examining the Risks of SME IPOs
While the SME IPO surge provides capital access for smaller businesses, it carries inherent risks. SME IPOs historically show higher volatility due to lower market liquidity and limited analyst coverage. Concerns include potential inflated valuations, as many SME IPOs have delivered flat or negative returns post-listing in recent years.
Data from early 2026 indicates that the average listing gain for SME IPOs has dropped sharply to 2.8%, with a majority of new listings opening below their offer price.
Furthermore, regulatory scrutiny on the SME segment has intensified. SEBI's reforms, introduced in March 2025, include stricter eligibility criteria, capped Offer for Sale (OFS) components, and stricter rules on IPO proceeds. These reforms aim to boost listing quality and curb speculation, promoting a fundamentals-based approach over momentum investing. Companies in sectors like pharmaceuticals, textiles, and auto ancillaries are generally in growth phases. The auto ancillary sector, in particular, is poised for expansion driven by increased vehicle production and EV adoption. However, the success of these IPOs will depend on their individual valuations and business models.
SME Illiquidity and Governance Concerns
The high volume of SME IPOs could lead to market saturation and divide investor attention. A substantial percentage of SME-listed companies have faced trading suspensions due to non-compliance, leaving investors trapped in illiquid securities.
High promoter shareholding and limited institutional oversight can lead to governance gaps, where promoters may focus on personal liquidity rather than long-term growth.
While attractive listing gains were common for SME IPOs in prior years, this trend has moderated significantly. In 2025, nearly half of SME listings traded below their IPO price, and average listing gains have dwindled. The focus is shifting towards fundamentals, with investors becoming more discerning about valuation comfort and subscription quality.
Companies with inadequate disclosures, inflated revenues, or undisclosed pre-IPO arrangements have historically undermined investor confidence. While individual SME issues are often smaller than mainboard offerings, the substantial minimum investment for some can still be a barrier for smaller retail investors.